Clinical trial
A Morbidity-Mortality and Remodeling Study With Valsartan
NCT00133328 · Jikei University School of Medicine, Other · Unknown status
Key facts
| NCT number | NCT00133328 |
|---|---|
| Title | A Morbidity-Mortality and Remodeling Study With Valsartan |
| Official title | A Morbi-Mortality and Remodeling Study With Valsartan in Patients With Hypertension and Cardiovascular Disease |
| Lead sponsor | Jikei University School of Medicine, Other |
| Status | Unknown status |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Hypertension, Ischemic Heart Disease, Congestive Heart Failure |
| Intervention type | Drug |
| Interventions | valsartan |
| Enrollment | 3,000 |
| Start date | Jan 1, 2002 |
| Completion | Nov 1, 2005 |
| First posted | Aug 23, 2005 |
| Last update posted | Oct 28, 2005 |
| Countries | Japan |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: